TScan Therapeutics to Participate in Needham Healthcare Conference

Got story updates? Submit your updates here. ›

TScan Therapeutics, Inc., a clinical-stage biotechnology company focused on developing T cell receptor (TCR)-engineered T cell (TCR-T) therapies for cancer treatment, announced that the company will participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference on April 15, 2026.

Why it matters

As a clinical-stage biotech company working on innovative cancer immunotherapies, TScan's participation in high-profile industry conferences like the Needham Healthcare Conference provides an opportunity to share updates on its pipeline and engage with potential investors and partners.

The details

The fireside chat will take place at 3:00 p.m. Eastern Time on April 15, 2026, and a webcast will be available on the company's website. TScan is currently focused on developing its lead TCR-T therapy candidate for the treatment of hematologic malignancies, as well as early-stage methods for in vivo engineering to treat solid tumors.

• The fireside chat will take place on Wednesday, April 15, 2026 at 3:00 p.m. Eastern Time.

What’s next

The webcast of the fireside chat will be available on the 'Events and Presentations' section of TScan's website, and an archived replay will be available for 90 days following the event.